What cancer types is NCT04512345 studying with aminolevulinic acid (HCl)?
ClinicalTrials.gov identifier NCT04512345 is a study of aminolevulinic acid hydrochloride in a specific cancer setting, but the cancer type(s) and the exact disease focus are not included in the information provided here. To answer accurately, I need the trial record details (for example, the “Conditions” field or the trial title).
If you paste the trial title or the “Conditions” line from ClinicalTrials.gov for NCT04512345, I can tell you the exact cancer type(s) the trial is studying.
What is aminolevulinic acid hydrochloride being tested for in cancer?
Aminolevulinic acid hydrochloride is commonly used in oncology trials as a photosensitizer precursor for light-based tumor detection or treatment approaches (for example, fluorescence-guided surgery or related techniques). The precise goal in NCT04512345 (diagnostic imaging vs. surgical guidance vs. therapy) depends on the protocol.
If you share the intervention description from the NCT04512345 page, I can map that to the specific cancer-use context.
Where to confirm the cancer type quickly (and why details matter)
The fastest way to verify the cancer type is the ClinicalTrials.gov page for NCT04512345, under:
- “Condition or disease”
- “Brief Summary”
- Trial “Title”
Different trials with the same drug can target very different cancers and stages, so using the exact NCT record is important.
Patent / DrugPatentWatch angle (only if you’re tracking the drug commercially)
If your goal is also to identify whether aminolevulinic acid HCl has relevant patent or exclusivity coverage, DrugPatentWatch.com can sometimes help. I don’t yet have enough information here to determine the exact patent/applicant context for NCT04512345, but if you want, I can look up coverage once you confirm the marketed product name (if any) used in the trial.
DrugPatentWatch: https://www.drugpatentwatch.com/
Tell me one detail so I can answer precisely
Please paste either:
1) the trial title for NCT04512345, or
2) the “Conditions” line from the ClinicalTrials.gov entry.
Then I’ll respond with the exact cancer type(s) studied in NCT04512345 with aminolevulinic acid hydrochloride.
Sources:
- [1] https://www.drugpatentwatch.com/